Cytokines, apoptosis and cachexia: the potential for TNF antagonism (Q34774468)

4 August 2017

1 reference

title

Cytokines, apoptosis and cachexia: the potential for TNF antagonism (English)

1 reference

4 August 2017

0 references

1 reference

Stefan D Anker

1 reference

4 August 2017

Rakesh Sharma

1 reference

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

International Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

161-171

1 reference

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumor necrosis factor and cachexia: a current perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Apoptosis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Chronic heart failure and micronutrients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumor Necrosis Factor and Steroid Metabolism in Chronic Heart Failure: Possible Relation to Muscle Wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Insulin resistance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Loss of bone mineral in patients with cachexia due to chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Hemodynamic Regulation of Tumor Necrosis Factor-α Gene and Protein Expression in Adult Feline Myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Systemic inflammation in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Uric acid in chronic heart failure: a marker of chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Exercise training for heart failure: coming of age

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Abnormalities of skeletal muscle in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Alterations of skeletal muscle in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Predictors of exercise capacity in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Oxidative stress is related to exercise intolerance in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Nitric oxide production during exercise in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cardiac myocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Regulation of insulin-like growth factor I receptor gene expression in normal and pathological states.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cancer cachexia: from experimental models to patient management

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cytokines and Their Role in the Pathophysiology of Cancer Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

The role of cytokines in the catabolic consequences of infection and injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Apoptosis in sepsis: a new target for therapeutic exploration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Apoptosis in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Cytokines and liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

Apoptosis: mechanisms and relation to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

HIV, cytokines and programmed cell death. A subtle interplay.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

NF-kappaB activation and HIV-1 induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900244-9

7 January 2021

10.1016/S0167-5273(02)00244-9

Identifiers

DOI

1 reference

4 August 2017

1 reference